This inventor holds 3 USPTO granted patents. Top assignees: Hankyu-Kyoei Bussan Co., Ltd., Itoham Foods Inc.. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ikeda, JP (1998)
- Osaka, JP (1999 - 2000)
Company Filing History:
Years Active: 1998-2000
Title: Hisako Matsutaka: Innovator in Biochemistry
Introduction
Hisako Matsutaka, a distinguished inventor based in Osaka, Japan, has made significant contributions to the field of biochemistry with a focus on health-related innovations. Holding three patents, Matsutaka's work reflects a commitment to addressing critical issues related to triglyceride levels, which play a significant role in cardiovascular health.
Latest Patents
Hisako Matsutaka's latest patents include:
1. Peptide inhibits blood triglyceride level
2. Peptide and formulations thereof inhibiting elevations of triglyceride
These groundbreaking developments have the potential to impact health solutions in managing lipid levels, showcasing his innovative approach to biochemistry and nutrition.
Career Highlights
Throughout his career, Hisako Matsutaka has contributed his expertise to prominent organizations such as Itoham Foods Inc. and Hankyu-Kyoei Bussan Co., Ltd. His work at these companies reflects a deep understanding of food science and health, leading to significant advancements in dietary products that promote better health outcomes.
Collaborations
Matsutaka has collaborated with notable experts, including Kyoichi Kagawa and Chizuko Fukuhama, who have provided valuable insights and expertise in their respective fields. These partnerships highlight the collaborative spirit within the scientific community, fostering innovation through shared knowledge and research efforts.
Conclusion
Hisako Matsutaka's contributions to innovations in biochemistry, particularly in the area of triglyceride management, underline his role as an influential inventor. With his ongoing commitment to research and development, Matsutaka continues to pave the way for future breakthroughs that can enhance health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile